Combining gemcitabine with MRK003, an experimental drug, triggers a chain of events leading to pancreatic cancer cell death, researchers from Cambridge reported in the Journal of Experimental Medicine. The researchers explained that when the two drugs are combined, the effect of each one is multiplied, thus intensifying the destruction of pancreatic cancer cells.
Professor David Tuveson, from the Cambridge Research Institute, UK, and team demonstrated in animal studies that MRK003, an experimental medication, when combined with chemotherapy medication gemcitabine, set off a domino effect which ultimately destroyed the malignant cells.
For the full article please go here.
Welcome to the AIHCP blog. Members, vistors and friends are welcome to post on our blog. We believe that knowledge and opinion should be shared. We are professional health care organization offering continuing education and certification programs in a wide array of health care speciality practices, including: Grief Counseling, Legal Nurse Consulting, Case Management, Stress Management, Holistic & Integrative Health Care & more. Join the Discussion!
No comments:
Post a Comment